Shandong Buchang Pharmaceuticals Co., Ltd.

¥15.10As of Sun 8 Nov 2026, 12:00 UTC
SSE:603858Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (11.62%)
Div yield 3.77%
ROE 1.27%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.28
PE TTM 56.11
TSR TTM (9.10%)
Mkt cap ¥15.67B
ROIC 2.75%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥17
11.21%
219.68%
Hold 0|7|6|3|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.32
0.32
0.36
0.36
3.59%
4.17%
17.21%
17.89%
Revenue¥B
0.995
0.975
0.990
1.005
3.94%
3.43%
0.22%
0.02%
Peers (US$2.349B)
Cap (US$)
PE
2.334B
28.62x
2.327B
12.89x
Capital
TTM
5Y
10Y
Leveragex
0.754
0.773
0.759
EBIT/Intx
2.192
0.173
0.220
Own earn%
(16.85)
(115.56)
(107.23)
Sh yield%
35.78
22.07
21.34
Owners
Insiders/Inst%
8.85
33.39
Short interest%
4.34
SBC / revenue%
2.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
0–3
$1 testx
—
Incr. ROIC%
1